An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Ritonavir; Tipranavir
- Indications HIV-1 infections
- Focus Adverse reactions; Expanded access
- Sponsors Boehringer Ingelheim
- 11 Apr 2012 Additional trial location (El Salvador) added as reported by ClinicalTrials.gov.
- 24 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Aug 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.